Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of High Concentration Hyaluronic Acid (HA) Transfer Medium in Repeated Implantation Failure (RIF) Patients

NCT04709796 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04709796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of High Concentration Hyaluronic Acid (HA) Transfer Medium in Repeated Implantation Failure (RIF) Patients
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Unknown status
Start date
March 3, 2021
Completion date
June 30, 2025
Enrollment
178 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

embryo loss, ivf, miscarriage, recurrent